Becton, Dickinson & Co. Stock
Becton, Dickinson & Co. Stock
We can see a decrease in the price for Becton, Dickinson & Co.. Compared to yesterday it has lost -€3.450 (-2.620%).
With 9 Buy predictions and not the single Sell prediction the community is currently very high on Becton, Dickinson & Co..
With a target price of 180 € there is a positive potential of 40.52% for Becton, Dickinson & Co. compared to the current price of 128.1 €.
Pros and Cons of Becton, Dickinson & Co. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Becton, Dickinson & Co. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Becton, Dickinson & Co. | -2.620% | 2.031% | 0.985% | -16.083% | -22.947% | -45.373% | -36.458% |
| Teleflex Inc. | -2.300% | 4.676% | 3.100% | 7.778% | 14.118% | -46.606% | -63.396% |
| Dexcom Inc. | -0.310% | 3.185% | 25.581% | -12.727% | 13.050% | -44.022% | -20.903% |
| Baxter International | -0.540% | 10.063% | 15.249% | -36.598% | 8.090% | -54.962% | -74.515% |
Comments
Becton, Dickinson and Company (BDX) had its price target lowered by Argus from $230.00 to $180.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BDX provided by MarketBeat
Becton, Dickinson and Company (NYSE:BDX) had its price target lowered by analysts at Jefferies Financial Group Inc. from $220.00 to $190.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BDX provided by MarketBeat
Becton, Dickinson and Company (NYSE:BDX) had its price target lowered by analysts at Citigroup Inc. from $233.00 to $232.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BDX provided by MarketBeat
News
Becton, Dickinson and Company Q2 Earnings Call Highlights
Becton, Dickinson and Company (NYSE:BDX) reported fiscal second-quarter revenue and adjusted earnings ahead of its internal
The Healthcare Stock Built for Investors Who Prioritize Capital Preservation
Wanting to invest in healthcare is a savvy instinct. It is, after all, a major expense in America. Per the Peterson-KFF Health System Tracker, "On a per capita basis, total health spending
